GlassScriptPhysician profile
Stefan Szczerba
NPI 1881685873
$28,969.26
in general payments reported to CMS, 2019-2025
27 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $203 · 2021: $2,422 · 2022: $1,742 · 2023: $902 · 2024: $720 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22,750.70 | 2019-2022 | |
| Mentor Worldwide LLC | $1,248.87 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $918.44 | 2021-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Bard Peripheral Vascular, INC. | $828.49 | 2021 | |
| Axogen | $550.35 | 2022-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Davol INC. | $449.85 | 2022 | |
| Motiva USA, LLC | $336.02 | 2025 | |
| Integra Lifesciences Corporation | $306.58 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| C. R. Bard, INC. & Subsidiaries | $226.65 | 2021 | |
| Galderma Laboratories, L.P. | $160.58 | 2019-2024 | |
| Tela Bio, INC. | $152.16 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Merz North America, INC. | $146.37 | 2022 | |
| Apyx Medical Corporation | $135.51 | 2019 | |
| Smith+Nephew, INC. | $95.68 | 2023-2024 | Stravix, Grafix Pl, Grafix |
| Kerecis Limited | $90.62 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $87.50 | 2025 | |
| Sientra, INC. | $81.99 | 2021-2022 | |
| Kci USA, INC. | $65.33 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $60.79 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $59.40 | 2023-2024 | Exparel, Iovera |
| Musculoskeletal Transplant Foundation INC. | $58.63 | 2022-2024 | |
| Medtronic, INC. | $53.93 | 2023 | V-Loc 180 |
| Coopersurgical, INC. | $32.37 | 2021 | |
| Urgo Medical North America, LLC | $23.85 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Masimo Corporation | $16.96 | 2023 | Sedline, Set and Rainbow Set |
| Polynovo North America LLC | $16.29 | 2024 | Novosorb Btm |
| Stryker Corporation | $15.35 | 2024 | 1788 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Szczerba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.